Application 075281
- Type
- ANDA
- Sponsor
- MYLAN PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | TABLET, DELAYED RELEASE;ORAL | 50MG | No | No |
| 003 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | TABLET, DELAYED RELEASE;ORAL | 75MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075281-002 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | 50MG | TABLET, DELAYED RELEASE / ORAL | AB | 2002-02-12 | |
| A075281-003 | DICLOFENAC SODIUM | DICLOFENAC SODIUM | 75MG | TABLET, DELAYED RELEASE / ORAL | AB | 2002-02-12 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A075281-002 | AB |
| A075281-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075281-002 | DICLOFENAC SODIUM | 50MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A075281-003 | DICLOFENAC SODIUM | 75MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075281-002 | DICLOFENAC SODIUM | 50MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075281-003 | DICLOFENAC SODIUM | 75MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075281-002 | DICLOFENAC SODIUM | 50MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075281-003 | DICLOFENAC SODIUM | 75MG | TABLET, DELAYED RELEASE / ORAL | 2002-02-12 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075281-002 | DICLOFENAC SODIUM | 50MG | TABLET, DELAYED RELEASE / ORAL | AB | 2002-02-12 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075281-003 | DICLOFENAC SODIUM | 75MG | TABLET, DELAYED RELEASE / ORAL | AB | 2002-02-12 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A075281-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A075281-003 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A075281-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A075281-003 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A075281-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A075281-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A075281-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A075281-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075281-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075281-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A075281-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A075281-003 | AB | 1 | 6a471c1ec25d… |
| 2019-12-13 00:20 UTC | 2019-12 | A075281-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A075281-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A075281-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A075281-003 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A075281-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A075281-003 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A075281-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A075281-003 | AB | 1 | ea99ee380514… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075281-002 | AB | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075281-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | NuCare Pharmaceuticals, Inc. | 5a852412-69af-6502-e063-6294a90a0748 | 2026-09-02 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Northwind Health Company, LLC | 5990259d-2f90-20d3-e063-6394a90a3d23 | 2026-08-21 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Northwind Health Company, LLC | 4dde6e36-7540-1cc3-e063-6294a90a3941 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | REMEDYREPACK INC. | 6e6a6f98-5517-4f67-9a6a-71019ba2d773 | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | A-S Medication Solutions | f92576d7-3ad9-43a3-8b10-3a29fbf712a4 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | A-S Medication Solutions | 6c57e330-ebbe-4165-84a8-4844b2f0097e | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
| DICLOFENAC SODIUM | DICLOFENAC SODIUM | Aurobindo Pharma Limited | 3487033c-7c62-4034-8718-73a7c49b26a0 | 2025-05-09 | Boxed warning, Warnings, Adverse reactions | 075281 ANDA075281 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-6280 | Diclofenac Sodium | diclofenac sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6280 | Diclofenac Sodium | diclofenac sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6281 | Diclofenac Sodium | diclofenac sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-6281 | Diclofenac Sodium | diclofenac sodium | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 51079-224 | Diclofenac Sodium | diclofenac sodium | Mylan Institutional Inc. | ANDA | Current |
| 51079-224 | Diclofenac Sodium | diclofenac sodium | Mylan Institutional Inc. | ANDA | Current |
| 51079-466 | Diclofenac Sodium | diclofenac sodium | Mylan Institutional Inc. | ANDA | Current |
| 68788-9185 | Diclofenac Sodium | diclofenac sodium | Preferred Pharmaceuticals, Inc. | ANDA | Current |